Inspire Medical Systems, Inc. Announces Presence at SLEEP 2026 and Publication of PREDICTOR Study

Inspire Medical Systems presented new clinical data at SLEEP 2026 demonstrating the effectiveness of its Inspire V hypoglossal nerve stimulation system for obstructive sleep apnea treatment. Key findings include significant reductions in hypoxic burden, improved cardiovascular outcomes compared to CPAP therapy, and higher patient adherence rates. The company also published studies identifying predictors for therapy eligibility and presented results from its 5,000-patient ADHERE registry showing 62% median AHI reduction.